Mazdutide
A Study of IBI362 in Participants With Obesity or Overweight
Innovent · Phase 3 · Completed · Enrollment 610
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Placebo | n/r | n/r | n/r | n/r | n/r |
| IBI362 4 mg | n/r | n/r | n/r | n/r | n/r |
| IBI362 6 mg | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.